Lihong Liu

机构：Wuhan University, First Hospital of Lanzhou University, Lanzhou University · ORCID：0000-0003-3128-8513

发表论文 218 篇 · 总被引 13079 次 · h-index 44

代表论文

• Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages (2024 · Emerging Microbes & Infections · 被引 60)
• Creation of Piezoelectricity in Quadruple Perovskite Oxides by Harnessing Cation Defects and Their Application in Piezo-Photocatalysis (2025 · ACS Nano · 被引 39)
• The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease (2025 · International Journal of Molecular Sciences · 被引 27)
• Unraveling the spatial organization and development of human thymocytes through integration of spatial transcriptomics and single-cell multi-omics profiling (2024 · Nature Communications · 被引 20)
• WITHDRAWN: Neutralizing Activity and Viral Escape of Pemivibart by SARS-CoV-2 JN.1 sublineages (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 9)
• Recombinant beta-galactosidase derived from Enterobacter cloacae Zjut HJ2001 for efficient biotransformation of galactooligosaccharides (2024 · Biochemical Engineering Journal · 被引 8)